We at Fenben™ Inc can make no medical claims about our products. However, we can cite and list resources of articles and studies about the ingredients in our products.
Fenbendazole is approved for animal usage only. Our products are for experimental use or research purposes. They are not FDA approved for humans and therefore we at Fenben Inc cannot support their usage as such. If you choose to use our products other than how they are suggested, you must do so at your own risk.
FACEBOOK GROUPS WE RECOMMEND
Fenbendazole for Dog Cancer
Fenbendazole and Other Alternative Choices
Fenbendazole Cancer Support
Mold and Morgellons Support Protocol
My Cancer Story Rocks
WEBSITES WE RECOMMEND
ABOUT OUR PRODUCTS
POTENTIAL USE IN CANCER
The article above states that Fenbendazole has the ability to fight cancer by halting the mitosis of cancer cells through multiple pathways.
1) It bonds to and disrupts the micotubulin of abnormal cells
2) It inhibits glucose delivery to cancer cells
3) It reduces glucose uptake in cancer cells by down regulating GLUT transporters
4) It acts as a kinase inhibitor which helps block the formation of new blood vessels necessary for tumors to survive
5) It stimulates the P53 to suppress and fight tumors
ADDITIONAL ARTICLES RELATING TO FENBENDAZOLE AND CANCER
"In this paper, the authors cite potential anti cancer mechanisms associated with Fenbendazole, including disruption of microtubule function and proteasomal interference, but it was also associated with blocking the glucose uptake by cancer cells (through reducing the expression of Glut-4 transporter as well as hexokinase) and thus starving cancer cells. This means Fenbendazole could also work nicely in supporting chemotherapy and radiotherapy as well as metabolic therapies. Because of the way it works (interacting with a site on tubulin similar to colchicine but distinct from that of Vinca alkaloids), Fenbendazole will not compete with Vinca alkaloids (such as Taxol) but instead will add to the anti cancer effect of these conventional treatments similar to other benzimidazoles."
"Indian scientists have found that fenbendazole, a broad-spectrum anti-parasitic drug used in veterinary sector, could be useful against cancers as well."
"Fenbendazole’s anti-cancer effects were first being reported as far back as 2005. It started when cancer researchers who were trying to implant cancer cells into laboratory animals were having a tough time getting the cancer cells to take hold. In some of the animals, the cancer cells kept dying off. Eventually, it was discovered that animals that had been treated with fenbendazole, to either get rid of or prevent parasites, were the ones that didn’t get cancer."
"Mice supplemented with both vitamins and fenbendazole exhibited significant inhibition of tumor growth."
"We tested the direct effects of benzimidazoles on human multiple myeloma cell proliferation and cell death induction. Albendazole, fenbendazole, and nocodazole significantly inhibited multiple myeloma cell proliferation with an IC50 value of 25 to 94 nmol/L for U266 multiple myeloma cells and an IC50 value of 63 to 380 nmol/L for H929 multiple myeloma cells."
"Fenbendazole as a Treatment for Diffuse Large B-Cell Lymphoma"
ARTICLES/STUDIES SUGGESTING FENBENDAZOLE CAN REPAIR AND PROTECT CELLS
FENBENDAZOLE INDUCES HMGB1
HMGB1 REPAIRS MITOCHONDRIA AND INCREASES LIFESPAN
FENBENDAZOLE FOR ALZHEIMERS/PARKINSONS/HUNTINGTONS/ALS
"Triclabendazole (TCBZ) and fenbendazole (FBDZ) have been discovered to extend the lifespan of yeast cells (a model for apoptosis), increase protection for cells from oxidative stress, and protect against cell death caused by Parkinson's disease-related protein alpha- synuclein. Both triclabendazole and fenbendazole can be used to extend the lifespan of eukaryotic cells, protect cells from oxidative stress, and treat various neurodegenerative diseases (e.g., Alzheimer's, Parkinson's, and Huntington's diseases) that involve toxic protein aggregates."